Monday, February 4, 2019

Cost effectiveness of early cancer surveillance

New research shows how early cancer screening and surveillance in patients with Li-Fraumeni syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.

from Latest Science News -- ScienceDaily http://bit.ly/2t7xtO5
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover a protein switch that burns fat and blocks new fat cells

A protein called “Mitch” may hold the key to a new generation of obesity treatments. Researchers found that disabling it in human cells boos...